Every Form 4 that Concentrix (CNXC) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow CNXC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CNXC filings page.
Concentrix Corp President and CEO Christopher A. Caldwell bought additional company stock in the open market. He purchased 1,000 shares of Common Stock at a price of $21.2497 per share. After this transaction, he directly owns 358,382 shares of Concentrix Common Stock.
Entities associated with Groupe Bruxelles Lambert reported a major sale of Concentrix Corp stock. FINPAR VI SA, FINPAR V SA and Sapiens S.a r.l. reported an open‑market sale of 6,000,000 shares of Concentrix common stock at $22.25 per share on April 29, 2026.
After this transaction, the reporting entities collectively report indirect ownership of 2,773,667 Concentrix shares, with 38,623 shares held by FINPAR VI SA, 35,964 by FINPAR V SA and 2,699,080 by Sapiens S.a r.l.
Concentrix Corp Chief Financial Officer Andre S. Valentine reported an open-market purchase of 2,500 shares of the company’s Common Stock. The shares were bought at an average price of $27.9477 per share, increasing his directly held position to 89,066 shares following the transaction.
Concentrix Corp President and CEO Christopher A. Caldwell reported an open-market purchase of company stock. On March 26, 2026, he bought 1,000 shares of Concentrix common stock at an average price of $26.97 per share. Following this transaction, he directly owns 357,382 shares of Concentrix common stock.
Concentrix Corp director LaVerne H. Council received an equity award of 7,701 shares of Common Stock in the form of restricted stock units. These RSUs were granted at no cash exercise price and increase her direct holdings to 17,704 shares following the award. The units vest in full on the earlier of the one-year anniversary of the grant date or the company’s 2027 Annual Meeting of Stockholders, aligning director compensation with long-term shareholder interests.
Cheng Chih-Kai reported acquisition or exercise transactions in this Form 4 filing.
Concentrix Corp director Cheng Chih-Kai received a grant of 7,701 shares of Common Stock as restricted stock units. These RSUs were awarded at no cash purchase price under the company’s 2020 Stock Incentive Plan and represent his entire reported direct holding after the transaction.
The restricted stock units will vest in full on the earlier of the one-year anniversary of the grant date or the date of Concentrix Corp’s 2027 Annual Meeting of Stockholders. This filing reflects a compensation-related equity award rather than an open-market share purchase or sale.
OGUT BILGE reported acquisition or exercise transactions in this Form 4 filing.
Concentrix Corp director Bilge Ogut received 7,701 shares of common stock as a restricted stock unit award. The grant was made at no cash cost to the director and represents equity-based compensation rather than an open-market purchase or sale.
According to the terms, these restricted stock units vest in full on the earlier of the one-year anniversary of the grant date or the date of Concentrix’s 2027 Annual Meeting of Stockholders. After this award, Ogut holds 7,701 shares directly, aligning personal ownership with shareholder interests through time-based vesting.
Deason Jennifer reported acquisition or exercise transactions in this Form 4 filing.
Concentrix Corp director Jennifer Deason received an equity award rather than buying shares on the market. She was granted 7,701 shares of common stock in the form of restricted stock units at no cash purchase price, increasing her direct holdings to 17,704 shares.
The restricted stock units were awarded under the 2020 Stock Incentive Plan and will vest in full on the earlier of the one-year anniversary of the grant date or the date of Concentrix’s 2027 Annual Meeting of Stockholders. This is a compensation-related grant, not an open-market transaction.
Hayley Kathryn reported acquisition or exercise transactions in this Form 4 filing.
Concentrix Corp director Hayley Kathryn received an equity award of 7,701 shares of Common Stock as restricted stock units under the 2020 Stock Incentive Plan. The units were granted at no cash cost and will vest in full on the earlier of the one-year anniversary of grant or the company’s 2027 Annual Meeting of Stockholders.
After this award, Kathryn directly holds 17,712.1206 shares. She also has an indirect holding of 3,034.2930 shares held by a trust, giving her both direct and trust-based exposure to Concentrix stock.
Marinello Kathryn V reported acquisition or exercise transactions in this Form 4 filing.
Concentrix Corp director Kathryn V. Marinello received an equity grant of 7,701 shares of common stock as restricted stock units. The award was made at no cash price under the 2020 Stock Incentive Plan and vests in full on the earlier of the one-year anniversary of the grant date or the issuer's 2027 Annual Meeting of Stockholders. Following this grant, she directly holds 17,704 shares of Concentrix common stock.
POLK DENNIS reported acquisition or exercise transactions in this Form 4 filing.
Concentrix Corp director Dennis Polk received an equity award of 7,701 shares of Common Stock in the form of restricted stock units. The grant was made at no cash cost per share and increased his direct holdings to 28,924 shares. These restricted stock units, awarded under the 2020 Stock Incentive Plan, vest in full on the earlier of the one-year anniversary of the grant date or the date of Concentrix’s 2027 Annual Meeting of Stockholders.
VEZINA ANN F reported acquisition or exercise transactions in this Form 4 filing.
Concentrix Corp director Ann F. Vezina received a grant of 7,701 shares of Common Stock in the form of restricted stock units. The award was made at no cash price and increases her direct holdings to 19,648 shares.
The restricted stock units were granted under the 2020 Stock Incentive Plan and will vest in full on the earlier of the one-year anniversary of the grant date or the date of Concentrix’s 2027 Annual Meeting of Stockholders.
Concentrix Corp executive Cormac J. Twomey reported a routine share transaction. On 02/01/2026, he disposed of 1,439 shares of Concentrix common stock in a transaction coded "F" at a price of $37.35 per share. Following this activity, he directly beneficially owned 56,995 common shares as EVP, Global Ops & Delivery.
Concentrix Corp President and CEO Christopher A. Caldwell, who also serves as a director, reported a disposition of company common stock. On 02/01/2026, he disposed of 5,693 shares at a price of $37.35 per share, in a transaction coded "F."
Following this transaction, Caldwell directly beneficially owned 356,382 shares of Concentrix common stock. The filing is made as a single‑person Form 4, reflecting his status as both an officer and director of the company.
Concentrix Corp's Chief Financial Officer reports a small share disposition. CFO Andre S. Valentine filed a Form 4 showing the disposition of 864 shares of Concentrix common stock on February 1, 2026, at a price of $37.35 per share under transaction code "F," typically used for tax withholding on equity awards.
After this transaction, Valentine directly beneficially owns 86,566 shares of Concentrix common stock. The filing reflects routine insider equity administration rather than a large open-market trade.
Concentrix Corp executive Gibson Craig, EVP of Global Sales and Account Management, reported a disposition of common stock in a Form 4 filing. On February 1, 2026, Craig disposed of 799 shares of Concentrix common stock at $37.35 per share. After this transaction, he directly owned 53,599 shares of Concentrix common stock.
Concentrix Corp executive Jane Fogarty, EVP, Legal, reported a disposition of Concentrix common stock. On 02/01/2026, 563 shares were disposed of at a price of $37.35 per share. Following this transaction, she directly beneficially owned 31,030 shares of Concentrix common stock.
Concentrix Corp President and CEO Christopher A. Caldwell reported buying additional company stock in an open-market transaction. On January 29, 2026, he purchased 1,000 shares of Concentrix common stock at a price of $37.07 per share, coded as a purchase transaction.
Following this trade, Caldwell beneficially owned 362,075 shares of Concentrix common stock, held in direct ownership. This filing reflects an increase in his personal equity stake and aligns his financial interests further with those of other shareholders.
Concentrix Corp President and CEO Christopher A. Caldwell reported routine equity compensation activity involving company common stock. On January 28, 2026, he acquired 2,855 shares of common stock at $0 per share upon the vesting of restricted stock units granted under the 2020 Stock Incentive Plan and tied to performance metrics over a three-year period ending November 30, 2025.
On the same date, 1,210 shares were withheld at a price of $36.32 per share, a transaction coded as "F," typically reflecting shares surrendered to cover tax obligations. After these transactions, Caldwell directly owned 361,075 shares of Concentrix common stock.
Concentrix Corp Chief Financial Officer Valentine Andre S reported stock transactions dated January 28, 2026. The filing shows an acquisition of 436 shares of common stock at $0 per share, tied to restricted stock units that vested under the 2020 Stock Incentive Plan after performance was measured over a three-year period ending November 30, 2025.
The report also shows a disposition of 130 shares of common stock at $36.32 per share on the same date. After these transactions, the executive directly held 87,430 shares of Concentrix common stock.
Concentrix Corp EVP Cormac J. Twomey reported routine equity compensation activity. On January 28, 2026, he acquired 491 shares of common stock at $0 upon vesting of performance-based restricted stock units granted under the 2020 Stock Incentive Plan. On the same date, 231 shares were disposed of at $36.32 per share, reflecting shares withheld to cover taxes. After these transactions, he directly owned 58,434 Concentrix common shares.
Concentrix Corp executive Jane Fogarty reported routine equity compensation activity. On January 28, 2026, she acquired 220 shares of common stock at $0 per share upon vesting of performance-based restricted stock units granted under the 2020 Stock Incentive Plan. On the same date, 79 shares were disposed of at $36.32 per share, typically reflecting shares withheld to cover taxes, leaving her with 31,593 shares of Concentrix common stock held directly.
Concentrix Corp President and CEO Christopher A. Caldwell reported a disposition of company common stock. On January 27, 2026, a transaction coded "F" involved 2,591 shares of Concentrix common stock at a price of $41.61 per share. Following this transaction, Caldwell beneficially owned 359,430 shares of Concentrix common stock in direct ownership.
Concentrix Corp executive Cormac J. Twomey reported a small share disposition under a Form 4 filing. On 01/27/2026, Twomey, EVP, Global Ops & Delivery, recorded a transaction in Common Stock coded "F" involving 495 shares at $41.61 per share. Following this transaction, he directly beneficially owned 58,174 shares of Concentrix common stock.
Concentrix Corp’s Chief Financial Officer, Valentine Andre S, reported a small stock disposition. On January 27, 2026, the CFO disposed of 278 shares of common stock at $41.61 per share, coded as transaction type “F.”
After this transaction, the filing shows the CFO directly beneficially owning 87,124 shares of Concentrix common stock. The filing is a routine Form 4 insider ownership update and does not describe any additional transactions or derivative securities activity.
Concentrix Corp executive Jane Fogarty, EVP, Legal, reported a small change in her holdings of Concentrix common stock. On January 27, 2026, she disposed of 168 shares of common stock at a price of $41.61 per share. After this transaction, she directly beneficially owns 31,452 shares of Concentrix common stock.
Concentrix Corp President and CEO Christopher A. Caldwell reported two share disposals of company common stock. On January 24, 2026, he disposed of 10,105 shares at $43.22 each. On January 26, 2026, he disposed of 1,751 shares at $42.69 each.
After these transactions, Caldwell directly beneficially owned 363,772 shares following the first transaction and 362,021 shares following the second transaction, reflecting his remaining direct common stock holdings in Concentrix Corp.
Concentrix Corp Chief Financial Officer Valentine Andre S reported two dispositions of Concentrix common stock. On January 24, 2026, 1,994 shares were disposed of at $43.22 per share, leaving 87,566 shares beneficially owned directly. On January 26, 2026, 164 shares were disposed of at $42.69 per share, leaving 87,402 shares of common stock held directly after the reported transactions.
Concentrix Corp executive Cormac J. Twomey, EVP, Global Ops & Delivery, reported two transactions in Concentrix common stock. On 01/24/2026, 2,893 shares were disposed of at $43.22 per share, and on 01/26/2026, 292 shares were disposed of at $42.69 per share. After these Form 4 reportable events, Twomey directly beneficially owned 58,669 shares of Concentrix common stock.
Concentrix Corp executive Gibson Craig reported a routine share disposition. On 01/24/2026, Craig, EVP, Global Sales, Acct Mgmt, disposed of 1,625 shares of Concentrix common stock at $43.22 per share. After this transaction, he directly beneficially owned 54,398 common shares.
Concentrix Corp executive Jane Fogarty reported routine share transactions in company stock. As EVP, Legal, she reported two non-derivative transactions in Common Stock coded "F" on January 24, 2026 and January 26, 2026.
The first transaction involved 1,319 shares at $43.22 per share, leaving her with 31,725 shares directly owned afterward. The second involved 105 shares at $42.69 per share, after which she directly owned 31,620 shares. All reported holdings are listed as directly owned.
Concentrix Corp reported that President and CEO Christopher A. Caldwell received an equity award in the form of restricted stock units. On 01/21/2026, he was granted 93,291 shares of common stock at a price of $0 per share, increasing his directly held beneficial ownership to 373,877 common shares after the award.
The filing explains that these 93,291 units are restricted stock units granted under the company’s 2020 Stock Incentive Plan. The units are scheduled to vest in three equal installments, with one-third of the shares vesting on each of the first three anniversaries of the grant date, tying the CEO’s compensation to the company’s long‑term performance.
Concentrix Corp executive Jane Fogarty, EVP, Legal, reported an equity award of common stock on a Form 4. On January 21, 2026, she acquired 13,913 shares of Concentrix common stock at a price of $0 per share, reflecting a grant of restricted stock units under the company’s 2020 Stock Incentive Plan.
The restricted stock units vest in three equal installments, with one-third of the shares vesting on each of the first three anniversaries of the grant date. Following this award, Fogarty beneficially owns 33,044 shares of Concentrix common stock directly.
Concentrix Corp executive Gibson Craig reported an equity award of company stock. On January 21, 2026, he received 15,015 shares of Common Stock at a price of $0 per share, reported as an acquisition. After this grant, he beneficially owned 56,023 shares of Concentrix Common Stock in total, held directly.
According to the footnote, the award represents restricted stock units granted under the 2020 Stock Incentive Plan. These restricted stock units vest in stages, with one-third of the shares vesting on each of the first three anniversaries of the grant date, meaning the executive earns the shares over a three-year period tied to continued service.
Concentrix Corp Chief Financial Officer reports stock award. CFO Valentine Andre S reported receiving 25,694 shares of Concentrix common stock on 01/21/2026, recorded at a price of $0 per share as an equity grant. These shares are in the form of restricted stock units awarded under the company’s 2020 Stock Incentive Plan. The units are scheduled to vest in three equal installments, with one-third of the shares vesting on each of the first three anniversaries of the grant date. Following this grant, the CFO beneficially owns 89,560 shares of Concentrix common stock, held directly.
Concentrix Corp. executive Cormac J. Twomey reported a stock-based compensation grant. On January 21, 2026, he acquired 26,724 shares of Common Stock of Concentrix Corp. through an award of restricted stock units under the company’s 2020 Stock Incentive Plan at a stated price of $0 per share. Following this grant, he beneficially owns 61,854 shares of Concentrix Common Stock in direct ownership. The restricted stock units vest in three equal annual installments, with one-third of the shares vesting on each of the first three anniversaries of the grant date, linking the award to continued service over time.
Concentrix Corporation (CNXC) reported an insider purchase by a reporting person who serves as President and CEO and Director. On 10/31/2025, the insider bought 1,000 shares of Common Stock at a price of $40 per share (Transaction Code: P), held as Direct (D) ownership. Following the transaction, the insider beneficially owns 287,661 shares.
Concentrix (CNXC) insider filing reports two transactions by the company’s President and CEO, who also serves as a Director. On 10/29/2025, the reporting person made a bona fide gift of 20,684 shares of common stock at $0, described as a transfer to a family trust in which the reporting person has no beneficial or pecuniary interest. Following this gift, the filing shows 284,661 shares held directly.
On 10/30/2025, the reporting person purchased 2,000 common shares at an average price of $42.0279, bringing direct beneficial ownership to 286,661 shares. Both holdings are reported as Direct (D) ownership.
Concentrix Corp (CNXC) reported an insider transaction by its EVP, Global Ops & Delivery. On October 30, 2025, the officer sold 500 shares of common stock at $42.53 per share. The filing states the sale was effected pursuant to a Rule 10b5-1 trading plan adopted on January 28, 2025.
Following this transaction, the reporting person beneficially owns 35,630 shares, held directly. This is a routine Form 4 disclosure of an executive’s equity transaction under a pre-established plan.
Concentrix (CNXC) reported an insider transaction by an executive officer. On 10/27/2025, a Form 4 shows a code F disposition of 1,403 shares of common stock at $46.04. After this transaction, the reporting person directly beneficially owns 41,008 shares. The filer is listed as EVP, Global Sales, Acct Mgmt, and the filing was made by one reporting person.
Concentrix (CNXC) reported an insider share purchase by its President & CEO, who is also a Director. On 10/10/2025, the executive bought 1,000 shares of common stock at $45.35 per share (transaction code P). Following the transaction, the executive beneficially owns 305,345 shares, held directly.
Christopher A. Caldwell, President and CEO and Director of Concentrix Corp (CNXC), reported a sale of common stock on 10/07/2025. The filing shows 390 shares were sold at $47.76, leaving Mr. Caldwell with 304,345 shares held directly after the transaction. The Form 4 was signed by an attorney-in-fact on 10/09/2025. No options or derivative transactions were reported.
Jane Fogarty, Executive Vice President, Legal at Concentrix Corp (CNXC), reported a sale of company stock on 10/05/2025. The Form 4 shows 126 shares sold at a price of $48.26 per share, leaving 19,131 shares beneficially owned directly after the transaction. The filing is signed by an attorney-in-fact on 10/07/2025.
Concentrix Corp director and President/CEO Christopher A. Caldwell reported three transactions on 09/30/2025. He acquired 1,000 shares of Common Stock at $47.435, exercised 9,363 employee stock options with an exercise price of $44.52, and had 8,990 shares withheld to satisfy the option exercise price and taxes. After these transactions the reported beneficial ownership totals shown on the form include 313,725 and similar post-transaction balances for direct holdings.
Twomey Cormac J, Executive Vice President, Global Ops & Delivery at Concentrix Corp (CNXC), reported a sale of 500 shares of the issuer's common stock on 09/30/2025 at a price of $47.08 per share. The filing states the sale was effected pursuant to a Rule 10b5-1 trading plan established on January 28, 2025. After the reported transaction the reporting person beneficially owns 36,130 shares, held directly. The Form 4 was filed as a single-person filing and bears an attorney-in-fact signature dated 10/02/2025.